BioHarvest Sciences ROA 2020-2024 | BHST
Current and historical return on assets (ROA) values for BioHarvest Sciences (BHST) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| BioHarvest Sciences ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2024-06-30 |
$-0.02B |
$0.03B |
-103.03% |
| 2024-03-31 |
$-0.02B |
$0.01B |
-152.00% |
| 2023-12-31 |
$-0.01B |
$0.02B |
-115.56% |
| 2023-09-30 |
$-0.01B |
$0.01B |
-92.31% |
| 2023-06-30 |
$-0.01B |
$0.01B |
-115.79% |
| 2023-03-31 |
$-0.01B |
$0.01B |
-114.29% |
| 2022-12-31 |
$-0.01B |
$0.01B |
-125.71% |
| 2022-09-30 |
$-0.01B |
$0.01B |
-111.11% |
| 2022-06-30 |
$-0.01B |
$0.01B |
-94.74% |
| 2022-03-31 |
$-0.01B |
$0.01B |
-52.63% |
| 2021-12-31 |
$-0.01B |
$0.01B |
-100.00% |
| 2021-09-30 |
$-0.01B |
$0.01B |
-125.71% |
| 2021-06-30 |
$-0.01B |
$0.01B |
-148.15% |
| 2021-03-31 |
$-0.01B |
$0.01B |
-236.36% |
| 2020-12-31 |
$-0.01B |
$0.01B |
-200.00% |
| 2020-06-30 |
$-0.00B |
$0.00B |
-266.67% |
| 2020-03-31 |
$-0.00B |
$0.00B |
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
|
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|
